In this Case Study, Oxford Biomedica, an innovative global gene and cell therapy company, describes:

• The automated system used for a 10-day cell-based workflow required for an analytical test to determine viral vector titer
• The advantages of Hamilton's CECULA Graphical User Interface (GUI) for the planning of long-term cell-based assays
• The transfer of the automated assay to Good Manufacturing Practice (GMP)

Brought to you by